Medicine and Dentistry
Peptoclostridium difficile
50%
Enzyme Immunoassay
50%
Infection
37%
Infectious Disease
33%
Clostridium Difficile Infection
25%
Health Care Cost
25%
Diagnosis of Clostridium Difficile
25%
Nucleic Acid Amplification
25%
Real Time Polymerase Chain Reaction
25%
Neisseria gonorrhoeae
25%
Chlamydia Trachomatis
25%
Genitourinary Medicine
25%
Cardiopulmonary Bypass
25%
Laboratory Diagnosis
25%
Virus Infection
25%
Fidaxomicin
25%
Mycobacterium Chimaera
25%
Polymerase Chain Reaction
25%
Mandatory Reporting
25%
Diagnostic Testing
25%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
25%
Chlamydiae
16%
Gonorrhea
16%
Laboratory Test
16%
Pathogen
12%
Prick Test
12%
C Reactive Protein
12%
Pediatrics
12%
Bacterial Infection
12%
Emergency Department
12%
Finger
12%
Molecular Spectroscopy
12%
Open Heart Surgery
12%
Waterborne Diseases
12%
Heart Surgery
12%
Decision Making
12%
Respiratory Syncytial Virus
12%
Bypass Surgery
12%
Diseases
12%
Whole Genome Sequencing
12%
Medical Device
12%
Infection Rate
8%
National Health Service
8%
Infection Control
8%
Infectious Diarrhea
8%
Glutamate Dehydrogenase
5%
Immunology and Microbiology
Peptoclostridium difficile
100%
Infectious Agent
50%
Influenza
37%
Laboratory Test
37%
Enzyme Immunoassay
37%
Prevalence
33%
Respiratory Syncytial Virus
31%
Turnaround Time
30%
Viral Disease
25%
Molecular Spectroscopy
25%
Drug Resistance
25%
Human Respiratory Syncytial Virus
25%
Antimicrobial Resistance
25%
Gastroenteritis
25%
Mycobacterium chimaera
25%
Multiplex Polymerase Chain Reaction
25%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
25%
Enterobacteriaceae
25%
Infection Rate
21%
C-Reactive Protein
20%
Leukocyte Count
16%
Nose
12%
Dynamics
12%
Microorganism Detection
12%
Decision Making
12%
Toxoid
12%
Repressor Gene
8%
All Cause Mortality
8%
Airborne Bacterium
8%
Waterborne Disease
8%
Clinical Microbiology
6%
Respiratory Virus
6%
Polymerase Chain Reaction
5%
Total Viable Count
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
90%
Infectious Agent
50%
Peptoclostridium difficile
50%
Diseases
45%
Enzyme Immunoassay
45%
Antiinfective Agent
37%
Feces microflora
25%
Fidaxomicin
25%
Human respiratory syncytial virus
25%
Neisseria gonorrhoeae
25%
Clostridium Difficile Infection
25%
Mandatory Reporting
25%
Influenza A
25%
Gastroenteritis
25%
Oseltamivir
25%
Virus Infection
25%
Guanosine Phosphate
25%
Gonorrhea
16%
Chlamydiae
16%
Respiratory Tract Infection
12%
Respiratory Virus
12%
Drug Resistance
12%
Antibiotics
12%
Antimicrobial Resistance
12%
Bacterial Infection
12%
C Reactive Protein
12%
Infectious Diarrhea
8%
Infection Rate
8%